Abstract:Abstract Background MicroRNAs have important roles in tumorigenesis. There is accumulating evidence of aberrant expression of miR-143 and miR-145 and their target gene KRAS has been described in colorectal cancer (CRC). We hypothesize that single nucleotide polymorphisms (SNPs) within or near mRNA-miRNA binding sites may affect miRNA/target gene interaction, resulting in differential mRNA/protein expression and promoting the development and progression of CRC.Methods We conducted a case-control study of 507 CRC cases recruited from a tertiary hospital and 497 population-based controls to assess the association of genetic polymorphisms in miR-143/145 and the KRAS 3′ untranslated region (3′ UTR) with CRC susceptibility and survival. Deaths and causes of death among the CRC cases were identified using the Hangzhou Cancer Registration System and Death Surveillance System. Genetic variations of genomic regions located from 500 bp upstream to 500 bp downstream of the miR-143/miR-145 gene and the 3′ UTR of KRAS were selected using the Haploview and HaploReg software. Results Using publicly available expression profiling data, we found that miR-143/145 and KRAS expression were all reduced in rectal cancer tissue compared with adjacent normal mucosa. The Rs74693964 C/T variant located 65 bp downstream of miR-145 genomic regions was observed to be associated with CRC susceptibility (adjusted odds ratio 2.414, 95% CI: 1.385–4.206). Among non-smokers, the miR-143 rs41291957 GA genotype and miR-145 rs74693964 CT genotype were borderline significantly associated with an increased risk of rectal cancer. However, there was no interaction effect between selected SNPs and smoking status. Cumulative effects of miR-143 and miR-145 on CRC risk were observed (Ptrend=0.03). CRC cases carrying variant genotype TT of KRAS rs712 had poorer survival (log-rank P=0.044, adjusted hazard ratio 4.328, 95% CI: 1.236–15.147). Conclusions Our results indicate that miRNA-related polymorphisms in miR-143/145 and KRAS are likely to be deleterious and represent potential biomarkers for CRC susceptibility and survival.

Polymorphisms of CD44 rs187115 as a Predictive Biomarker in Early Colorectal Cancer Diagnostic

Polymorphisms of a Novel Long Non-Coding RNA RP11-108K3.2 with Colorectal Cancer Susceptibility and Their Effects on Its Expression

Association of a Novel Genetic Variant in RP11-650L12.2 with Risk of Colorectal Cancer in Han Chinese Population.

Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations

-196 to -174Del, Rs4696480, Rs3804099 Polymorphisms of Toll-like Receptor 2 Gene Impact the Susceptibility of Cancers: Evidence from 37053 Subjects

A Novel SNP in Promoter Region of RP11-3N2.1 is Associated with Reduced Risk of Colorectal Cancer

Association of CD44 gene rs13347 polymorphism with occurrence and metastasis of breast cancer

Colorectal Cancer Risk Prediction Using the rs4939827 Polymorphism of the SMAD7 Gene in the Romanian Population

Functional Polymorphisms in the CD44 Gene and Acute Myeloid Leukemia Cancer Risk in a Chinese Population.

Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women

Associations of five polymorphisms in the CD44 gene with cancer susceptibility in Asians

A Polymorphism Rs4705341 in the Flanking Region of Mir-143/145 Predicts Risk and Prognosis of Colorectal Cancer.

Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer.

CD44 Rs13347 C>T Polymorphism Predicts Breast Cancer Risk and Prognosis in Chinese Populations

ATG 16 L 1 rs 2241880 polymorphism predicts unfavorable clinical outcomes for colorectal cancer patients in the Chinese population

No Association Between the Polymorphisms in CDX2 Coding Regions and Colorectal Cancer in Chinese

A Functional Variant Rs353292 in the Flanking Region of Mir-143/145 Contributes to the Risk of Colorectal Cancer

Lack of Association Between BsmI and FokI Polymorphisms of the VDR Gene and Sporadic Colorectal Cancer in a Romanian Cohort—A Preliminary Study

Polymorphisms in Microrna Genes As Predictors of Clinical Outcomes in Colorectal Cancer Patients.

Analyzing Large-Scale Samples Confirms the Association Between Rs16892766 Polymorphism and Colorectal Cancer Susceptibility

Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival